Effects of canagliflozin on major adverse cardiovascular events by baseline estimated glomerular filtration rate: Pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 12, doi. 10.1111/dom.14539

By:

• Weir, Matthew R.;
• Gogate, Jagadish;
• Damaraju, C.V.;
• Correa‐Rotter, Ricardo;
• Mahaffey, Kenneth W.

Publication type:

Article